Cisco
CSCO
Alibaba
BABA
Disney
DIS
4
Apple
AAPL
5
Adobe
ADBE
US Stock MarketDetailed Quotes
COCP Cocrystal Pharma
- 1.5200
- +0.0400+2.70%
Trading Mar 26 11:16 ET
15.46MMarket Cap-0.83P/E (TTM)
1.5600High1.5000Low8.01KVolume1.5000Open1.4800Pre Close12.15KTurnover0.11%Turnover RatioLossP/E (Static)10.17MShares3.260052wk High1.22P/B10.66MFloat Cap1.350052wk Low--Dividend TTM7.01MShs Float77.4000Historical High--Div YieldTTM4.05%Amplitude1.3250Historical Low1.5170Avg Price1Lot Size
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
Cocrystal Pharma Stock Forum
Cocrystal Pharma Reports Phase 1 Results with Oral, Broad-Acting Antiviral Drug CDI-988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections
Wednesday, 8th January at 8:00 am
• Data show favorable safety and tolerability with dosing up to 800 mg for 10 days
• Plans to initiate human challenge study in 2025 in norovirus-infected subjects
BOTHELL, Wash., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP) ("Cocry...
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...
Cocrystal Pharma Reports Favorable Results from Single-Ascending Dose Cohorts of Phase 1 Study with CDI-988, its Oral Pan-Viral Norovirus/Coronavirus Protease Inhibitor
Cocrystal Pharma (Nasdaq: COCP) reported favorable safety and tolerability results from the single-ascending dose (SAD) cohorts of its Phase 1 study for CDI-988, an oral pan-viral norovirus/coronavirus protease inhibitor.
The study, conducted in Australia, evaluated doses ranging from 100 mg to 60...
NEWS
Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza
$AeroClean Technologies (AERC.US)$ $Bit Brother (BTB.US)$ $Cocrystal Pharma (COCP.US)$ $FingerMotion (FNGR.US)$ $GLOBAL TECH INDUSTRIES GROUP INC (GTII.US)$ $Home Depot (HD.US)$ $Oncternal Therapeutics (ONCT.US)$ $Pinterest (PINS.US)$ $Rivian Automotive (RIVN.US)$ $Snap Inc (SNAP.US)$ $SOBR Safe (SOBR.US)$ $Twitter (Delisted) (TWTR.US)$
No comment yet